Prevalence of direct antiglobulin test positive in whole blood donors: Study at a tertiary blood center Northern India

BACKGROUND: The direct antiglobulin test (DAT) detects red blood cell (RBC) sensitivity to complement or IgG in vivo. The clinical disorders of hemolytic disease of the newborn, hemolytic transfusion reaction, and autoimmune and drug-induced hemolytic anemia are some examples of those that can cause...

Full description

Saved in:
Bibliographic Details
Main Authors: Jyoti Bharti, Archana Solanki, Ashutosh Singh, Mallika Agarwal, Tulika Chandra
Format: Article
Language:English
Published: Wolters Kluwer Medknow Publications 2024-12-01
Series:Asian Journal of Transfusion Science
Subjects:
Online Access:https://journals.lww.com/10.4103/ajts.ajts_188_23
Tags: Add Tag
No Tags, Be the first to tag this record!
_version_ 1841554836444676096
author Jyoti Bharti
Archana Solanki
Ashutosh Singh
Mallika Agarwal
Tulika Chandra
author_facet Jyoti Bharti
Archana Solanki
Ashutosh Singh
Mallika Agarwal
Tulika Chandra
author_sort Jyoti Bharti
collection DOAJ
description BACKGROUND: The direct antiglobulin test (DAT) detects red blood cell (RBC) sensitivity to complement or IgG in vivo. The clinical disorders of hemolytic disease of the newborn, hemolytic transfusion reaction, and autoimmune and drug-induced hemolytic anemia are some examples of those that can cause in vivo coating of RBCs with antibodies or complement autoimmune hemolytic anemia (AIHA). Rarely, DAT is positive in nonimmune-mediated hemolytic anemias as well. Standard donor screening techniques do not require the DAT to be performed. AIMS AND OBJECTIVES: The aim of the study was to assess the prevalence of DAT positive in healthy blood donors at a tertiary blood center in North India. MATERIALS AND METHODS: This 2-year prospective observational study included whole blood donors from January 2020 to December 2022. A total of 152,564 healthy blood donors including 150,246 (98.5%) males and 2318 (1.5%) females were donated at the department of transfusion medicine. RESULTS: Of a total of 152,564 donors, 150,246 (98.5%) were male, and 2,318 (1.5%) were female. Among the male donors, 11 (0.007%) had a history of blood transfusion and 16 (0.011%) tested DAT positive. Among the female donors, 15 (0.647%) had a history of blood transfusion and none of them tested DAT positive. CONCLUSION: We observed low levels of DAT positivity in healthy blood donors. Such donors should be regularly monitored to check for any long-term development of malignancies or clinical or laboratory indications of hemolysis. DAT-positive blood units do not supply the recipient at risk, which may cause negative consequences.
format Article
id doaj-art-f149757ba0c94576979c375e24b6065a
institution Kabale University
issn 0973-6247
1998-3565
language English
publishDate 2024-12-01
publisher Wolters Kluwer Medknow Publications
record_format Article
series Asian Journal of Transfusion Science
spelling doaj-art-f149757ba0c94576979c375e24b6065a2025-01-08T09:08:05ZengWolters Kluwer Medknow PublicationsAsian Journal of Transfusion Science0973-62471998-35652024-12-0118223724110.4103/ajts.ajts_188_23Prevalence of direct antiglobulin test positive in whole blood donors: Study at a tertiary blood center Northern IndiaJyoti BhartiArchana SolankiAshutosh SinghMallika AgarwalTulika ChandraBACKGROUND: The direct antiglobulin test (DAT) detects red blood cell (RBC) sensitivity to complement or IgG in vivo. The clinical disorders of hemolytic disease of the newborn, hemolytic transfusion reaction, and autoimmune and drug-induced hemolytic anemia are some examples of those that can cause in vivo coating of RBCs with antibodies or complement autoimmune hemolytic anemia (AIHA). Rarely, DAT is positive in nonimmune-mediated hemolytic anemias as well. Standard donor screening techniques do not require the DAT to be performed. AIMS AND OBJECTIVES: The aim of the study was to assess the prevalence of DAT positive in healthy blood donors at a tertiary blood center in North India. MATERIALS AND METHODS: This 2-year prospective observational study included whole blood donors from January 2020 to December 2022. A total of 152,564 healthy blood donors including 150,246 (98.5%) males and 2318 (1.5%) females were donated at the department of transfusion medicine. RESULTS: Of a total of 152,564 donors, 150,246 (98.5%) were male, and 2,318 (1.5%) were female. Among the male donors, 11 (0.007%) had a history of blood transfusion and 16 (0.011%) tested DAT positive. Among the female donors, 15 (0.647%) had a history of blood transfusion and none of them tested DAT positive. CONCLUSION: We observed low levels of DAT positivity in healthy blood donors. Such donors should be regularly monitored to check for any long-term development of malignancies or clinical or laboratory indications of hemolysis. DAT-positive blood units do not supply the recipient at risk, which may cause negative consequences.https://journals.lww.com/10.4103/ajts.ajts_188_23direct antiglobulin testdonationhealthy donorsprevalencescreening
spellingShingle Jyoti Bharti
Archana Solanki
Ashutosh Singh
Mallika Agarwal
Tulika Chandra
Prevalence of direct antiglobulin test positive in whole blood donors: Study at a tertiary blood center Northern India
Asian Journal of Transfusion Science
direct antiglobulin test
donation
healthy donors
prevalence
screening
title Prevalence of direct antiglobulin test positive in whole blood donors: Study at a tertiary blood center Northern India
title_full Prevalence of direct antiglobulin test positive in whole blood donors: Study at a tertiary blood center Northern India
title_fullStr Prevalence of direct antiglobulin test positive in whole blood donors: Study at a tertiary blood center Northern India
title_full_unstemmed Prevalence of direct antiglobulin test positive in whole blood donors: Study at a tertiary blood center Northern India
title_short Prevalence of direct antiglobulin test positive in whole blood donors: Study at a tertiary blood center Northern India
title_sort prevalence of direct antiglobulin test positive in whole blood donors study at a tertiary blood center northern india
topic direct antiglobulin test
donation
healthy donors
prevalence
screening
url https://journals.lww.com/10.4103/ajts.ajts_188_23
work_keys_str_mv AT jyotibharti prevalenceofdirectantiglobulintestpositiveinwholeblooddonorsstudyatatertiarybloodcenternorthernindia
AT archanasolanki prevalenceofdirectantiglobulintestpositiveinwholeblooddonorsstudyatatertiarybloodcenternorthernindia
AT ashutoshsingh prevalenceofdirectantiglobulintestpositiveinwholeblooddonorsstudyatatertiarybloodcenternorthernindia
AT mallikaagarwal prevalenceofdirectantiglobulintestpositiveinwholeblooddonorsstudyatatertiarybloodcenternorthernindia
AT tulikachandra prevalenceofdirectantiglobulintestpositiveinwholeblooddonorsstudyatatertiarybloodcenternorthernindia